1. 77‐Year‐Old Woman with a Dural‐Based Mass. (January 2015) Authors: Okimoto, Ross A.; Perry, Arie; Rubenstein, James L. Journal: Brain pathology Issue: Volume 25:Number 1(2015:Jan.) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report. Issue 3 (7th June 2022) Authors: Goyal, Vanshika; Salmasi, Giselle; Leavitt, Andrew D.; Rubenstein, James L.; Banerjee, Rahul Journal: EJHaem Issue: Volume 3:Issue 3(2022) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Can rituximab unlock the innate potential of checkpoint blockade in the CNS?. Issue 2 (28th January 2019) Authors: Rubenstein, James L. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 2(2019) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term survival in AIDS-related primary central nervous system lymphoma. Issue 1 (30th August 2016) Authors: Gupta, Neel K.; Nolan, Amber; Omuro, Antonio; Reid, Erin G.; Wang, Chia-Ching; Mannis, Gabriel; Jaglal, Michael; Chavez, Julio C.; Rubinstein, Paul G.; Griffin, Ann; Abrams, Donald I.; Hwang, Jimmy; Kaplan, Lawrence D.; Luce, Judith A.; Volberding, Paul; Treseler, Patrick A.; Rubenstein, James L. Journal: Neuro-oncology Issue: Volume 19:Issue 1(2017) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low‐dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma. (3rd February 2019) Authors: Vu, Khoan; Mannis, Gabriel; Hwang, Jimmy; Geng, Huimin; Rubenstein, James L. Journal: British journal of haematology Issue: Volume 186:Number 1(2019) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. On point in primary CNS lymphoma. Issue 5 (3rd July 2020) Authors: Tsang, Mazie; Cleveland, Joseph; Rubenstein, James L. Journal: Hematological oncology Issue: Volume 38:Issue 5(2020) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation. Issue 32 (10th November 2022) Authors: Rubenstein, James L. Journal: Journal of clinical oncology Issue: Volume 40:Issue 32(2022) Page Start: 3681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Primary CNS lymphoma: update on molecular pathogenesis and therapy. Issue 1 (2nd January 2023) Authors: Mo, Shirley S.; Cleveland, Joseph; Rubenstein, James L. Journal: Leukemia & lymphoma Issue: Volume 64:Issue 1(2023) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Progress in central nervous system lymphomas. (16th May 2014) Authors: Wang, Chia‐Ching; Carnevale, Julia; Rubenstein, James L. Journal: British journal of haematology Issue: Volume 166:Number 3(2014:Aug.) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System. (17th November 2015) Authors: Shalabi, Haneen; Angiolillo, Anne; Vezina, Gilbert; Rubenstein, James L.; Pittaluga, Stefania; Raffeld, Mark; Marcus, Leigh Journal: Pediatric hematology and oncology Issue: Volume 32:Number 8(2015) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗